American International Group, Inc. 9 Meters Biopharma, Inc. Transaction History

American International Group, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.26 - $0.64 $29,225 - $71,940	-112,407 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$0.52 - $1.0 $4,114 - $7,913	-7,913 Reduced 6.58%	112,407 $67,000
Q4 2021 Feb 11, 2022	SELL	$0.85 - $1.33 $1,661 - $2,600	-1,955 Reduced 1.6%	120,320 $118,000
Q3 2021 Nov 12, 2021	BUY	$1.03 - $1.41 $3,287 - $4,500	3,192 Added 2.68%	122,275 $159,000
Q2 2021 Aug 13, 2021	BUY	$1.04 - $1.5 $123,846 - $178,624	119,083 New	119,083 $131,000

67.9K

Ticker NMTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 12,955,400
Market Cap $259K
Description
9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders. The company is developing Larazotide, an 8-amino acid peptide, which is in Phase 3 clinical trial for the treatment of celiac disease, as we...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.